0001225208-24-001958.txt : 20240213
0001225208-24-001958.hdr.sgml : 20240213
20240213172756
ACCESSION NUMBER: 0001225208-24-001958
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240209
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cordani David
CENTRAL INDEX KEY: 0001318751
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38769
FILM NUMBER: 24630223
MAIL ADDRESS:
STREET 1: THE CIGNA GROUP
STREET 2: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cigna Group
CENTRAL INDEX KEY: 0001739940
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 824991898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
BUSINESS PHONE: 8602266000
MAIL ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
FORMER COMPANY:
FORMER CONFORMED NAME: Cigna Corp
DATE OF NAME CHANGE: 20181221
FORMER COMPANY:
FORMER CONFORMED NAME: Halfmoon Parent, Inc.
DATE OF NAME CHANGE: 20180508
4
1
doc4.xml
X0508
4
2024-02-09
0001739940
Cigna Group
CI
0001318751
Cordani David
900 COTTAGE GROVE ROAD
BLOOMFIELD
CT
06002
1
1
Chairman & CEO
1
Common Stock, $.01 Par Value
2024-02-09
4
M
0
38065.0000
139.2200
A
367386.0000
D
Common Stock, $.01 Par Value
2024-02-09
4
S
0
38065.0000
335.2193
D
329321.0000
D
Common Stock, $.01 Par Value
2024-02-12
4
M
0
2073.0000
139.2200
A
331394.0000
D
Common Stock, $.01 Par Value
2024-02-12
4
S
0
213.0000
335.3568
D
331181.0000
D
Common Stock, $.01 Par Value
2024-02-12
4
S
0
644.0000
337.3712
D
330537.0000
D
Common Stock, $.01 Par Value
2024-02-12
4
S
0
1216.0000
336.7600
D
329321.0000
D
Common Stock, $.01 Par Value
2024-02-13
4
M
0
7462.0000
139.2200
A
336783.0000
D
Common Stock, $.01 Par Value
1727.2938
I
By 401(k)
Common Stock, $.01 Par Value
99918.0000
I
By GRAT
Common Stock, $.01 Par Value
153801.0000
I
By Trust
Employee Stock Option (Right to Buy)
139.2200
2024-02-09
4
M
0
38065.0000
0.0000
D
2017-03-01
2026-03-01
Common Stock, $.01 Par Value
38065.0000
104736.0000
D
Employee Stock Option (Right to Buy)
139.2200
2024-02-12
4
M
0
2073.0000
0.0000
D
2017-03-01
2026-03-01
Common Stock, $.01 Par Value
2073.0000
102663.0000
D
Employee Stock Option (Right to Buy)
139.2200
2024-02-13
4
M
0
7462.0000
0.0000
D
2017-03-01
2026-03-01
Common Stock, $.01 Par Value
7462.0000
95201.0000
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.
Reflects the transfer by the Reporting Person's grantor retained annuity trust of 113,677 shares on January 26, 2024 of common stock in respect of a payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust.
Represents the weighted average price of the shares sold. The prices actually received ranged from $335.00 to $335.68 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Represents the weighted average price of the shares sold. The prices actually received ranged from $335.00 to $335.76 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Represents the weighted average price of the shares sold. The prices actually received ranged from $337.10 to $337.85 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Represents the weighted average price of the shares sold. The prices actually received ranged from $336.08 to $337.07 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.
Exhibit List: EX-24 Power of Attorney poacordani.txt
Matthew Arnold, attorney-in-fact
2024-02-13
EX-24
2
poacordani.txt
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned, a Director and Officer
of The Cigna Group, a Delaware corporation ("Cigna"), hereby makes,
designates, constitutes and appoints NICOLE S. JONES, KARI KNIGHT STEVENS,
ANDREA NELSON, JILL STADELMAN, SHERMONA MAPP AKOTIA and MATTHEW ARNOLD, each
acting individually, as the undersigned's true and lawful attorneys-in-fact and
agents, with full power and authority to act in the undersigned's capacity as a
Director and Officer of The Cigna Group for and in the name, place and stead of
the undersigned to execute and deliver:
(A) in connection with the filing with the Securities and Exchange Commission
pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934,
both as amended, of:
(i) Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934, Forms 144 in accordance with Rule 144 promulgated under
the Securities Act of 1933 and any and all other documents related thereto
(including, but not limited to, Seller's Representation Letters) and to take
further action as they, or any of them, deem appropriate in connection with the
foregoing.
Such attorneys-in-fact and agents, or any of them, are also hereby granted full
power and authority, on behalf of and in the name, place and stead of the
undersigned, to execute and deliver any and all such other documents, and to
take further action as they, or any of them, deem appropriate in connection with
the foregoing. The powers and authorities granted herein to such
attorneys-in-fact and agents, and each of them, also include the full right,
power and authority to effect necessary or appropriate substitutions or
revocations.
The undersigned hereby ratifies, confirms, and adopts, as his or her own act and
deed, all action lawfully taken by such attorneys-in-fact and agents, or any
of them, or by their respective substitutes, pursuant to the powers and
authorities herein granted. This Power of Attorney with respect to Forms 3, 4, 5
and 144 shall remain in full force and effect until:, the undersigned no
longer has responsibilities relating to Section 16 of the Securities Exchange
Act of 1934 or Rule 144 promulgated under the Securities Act of 1933 with
respect to the undersigned's beneficial ownership of securities of The Cigna
Group, unless earlier revoked by the undersigned in a signed writing to each
such attorney in fact.
IN WITNESS WHEREOF, the undersigned has executed this document as of the 2nd day
of January, 2024.
__/s/ David M Cordani__________
Signature
David M Cordani_______________
Print Name